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Abstract: Embryoid bodies have a number of similarities with cells in gastrulation, which provides useful biological
information about embryonic stem cell differentiation. Extensive research has been done to study the control of
embryoid body-mediated embryonic stem cell differentiation in various research fields. Recently, microengineering
technology has been used to control the size of embryoid bodies and to direct lineage specific differentiation of
embryonic stem cells. However, the underlying biology of developmental events in the embryoid bodies of different
sizes has not been well elucidated. In this study, embryoid bodies with different sizes were generated within micro-
fabricated PEG microwell arrays, and a series of gene and molecular expressions related to early developmental
events was investigated to further elucidate the size-mediated differentiation. The gene and molecular expression
profile suggested preferential visceral endoderm formation in 450 µm embryoid bodies and preferential lateral plate
mesoderm formation in 150 µm embryoid bodies. These aggregates resulted in higher cardiac differentiation in 450 µm
embryoid bodies and higher endothelial differentiation in 150 µm embryoid bodies, respectively. Our findings may
provide further insight for understanding embryoid body size-mediated developmental progress.
Keywords: microwell, embryoid body size, differentiation, lateral plate mesoderm, visceral endoderm.
Introduction
Embryonic stem cells (ESCs) have received extensive
attention in the field of cell biology and applied science due
to their pluripotency. Hence, extensive research on differen-
tiation of ESCs has been done using various in vitro culture
techniques. ESCs are known to initiate a range of tissue-spe-
cific differentiation via the formation of tissue-like spheroids
called embryoid bodies (EBs).19 EB development recapitu-
lates many aspects of early embryogenesis with various gene
expressions following the time-dependent sequence of the
lineage commitment events to form three germ layers.1-22
During EB formation, polarized mesendoderm is known to
develop intermediately via epithelial-to-mesenchymal transi-
tion and generate mesoderm and endoderm.8 EBs temporally
express genes in a manner that recapitulates the sequence of
normal development resulting in eventual early cell specifi-
cation prior to organogenesis.21 Expression of phenotypic
markers of endoderm such as Forkhead box protein A2 (Foxa2),
Sex determining region Y-related HMG box17 (Sox17), GATA
binding protein 4 (Gata4), and α-fetoprotein (Afp), and meso-
derm such as Brachyury-T, Felal liver kinase-1 (Flk1), and
Wingless-type MMTV integration site family. member 3A (Wnt3a)
demonstrate the ability of EBs to generate cells for cardio-
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vascular development.13 However, the typical heterogeneity
in the differentiation of EBs hinders production of defined cell
types, which can be modulated by culture methods for EB for-
mation. It is reported that in vitro cardiac mesoderm formation
and subsequent cardiogenic differentiation occurs after 5
days of culture.15-24 On the other hand, although the culture time
of EBs has been considered as an important parameter to induce
ESC differentiation via three germ layer formation, ESC dif-
ferentiation was recently reported to be also influenced by EB
sizes accompanied with culture time.5
In recent years, various microscale technologies have been
applied to control stem cell differentiation fate, and micro-
fabrication technique has provided an efficient tool to control
EB size homogenously.9,27,28 In our previous study, a polyeth-
ylene glycol (PEG) hydrogel microwell array was developed
as an ESC culture platform,9 enabling control over homoge-
nous EB size. It was demonstrated that microwell-mediated
EB size control induced a differential lineage commitment;
namely, a higher fraction of larger EBs (450 µm) showed
preferential differentiation towards the cardiogenic lineage,
whereas a greater number of endothelial cells were generated
in smaller EBs (150 µm).27 The differential expression of
Wnt5a and Wnt11, two members of the noncanonical WNT
pathway, was found to be directly involved in the EB size-
mediated differentiation into cardiac and endothelial lineage.
There is a recent study reporting that endothelial differentia-
tion of ESCs could be optimized by screening size-varying
EBs produced by a size-tunable concave microwell array.54
Another intriguing report has been recently published, which
demonstrated that novel size-controllable 3D-configurations
of ESCs could direct hepatic differentiation of ESCs.55 How-
ever, upstream developmental events to influence such differen-
tial ESC differentiation through the control of the colony sizes
have not been elucidated.
Therefore, the central aim of this study is to characterize
the differentiation process for elucidating the underlying biol-
ogy to determine EB size-mediated differential cardiac and
endothelial differentiation. To achieve this, different sized EBs
(150 and 450 µm) were generated homogenously using a
previously established PEG microwell array (150 and 450 µm
in diameter) culture platform, and a series of gene and molecular
expressions related to early developmental events was inves-
tigated. In particular, we tested if the formation of visceral endo-
derm-like cells in larger EBs (450 µm) may enhance cardiogenic
differentiation, whereas the preferential development of lateral
plate mesoderm in smaller EBs (150 µm) induced higher
endothelial differentiation.
Experimental
Fabrication of Hydrogel Microwell Platforms. Microwell
patterns with 150 and 450 µm diameters were generated on a
silicon wafer by using an SU-8 photoresist (MicroChem Corp.).
Polydimethylsiloxane (PDMS) stamps were used to mold PEG
microwells. The PDMS stamps were fabricated by pouring a
mixture (10:1) of silicone elastomer base solution and curing
agent (Sylgard 184, Essex Chemical) on the patterned silicon
master. PEG monomer solution was prepared with PEG
dimethacrylate 1,000 (Polysciences, Inc.) mixed with 1% (w/w)
of the photoinitiator, Irgacure 2959 (Ciba Specialty Chemicals
Corp). Glass slides (75 mm × 25 mm; Fisher) were treated with
3-(trimethoxysilyl) propylmethacrylate (TMSPMA) (Sigma)
for 30 min and baked at 70 oC overnight to mount the PEG
hydrogel on the surface of the glass substrate. About 200 µL
of PEG monomer solution was poured on the TMSPMA-treated
glass, and a microfabricated PDMS stamp was placed over
the solution. The monomers were cross-linked by exposure to
UV light (350-500 nm wavelength, 100 mW/cm2) for 30 s. After
peeling off the PDMS stamp, the remaining PEG hydrogel
microwell on the substrate was sterilized with 70% ethanol
and washed with Phosphate buffered saline (PBS) overnight
before use.
ESC and EB Cultures. Wild type (R1 and E14-Tg2a cell
line) or genetically engineered murine ESCs that expressed
green fluorescence protein (GFP) upon expression of Oct4
(R1) or Gsc (E14-Tg2a) promoter were cultured on tissue culture
flasks coated with 0.1% gelatin (Sigma) using high glucose
Dulbecco’s Modified Eagles Medium (DMEM; Invitrogen)
supplemented with 10% (v/v) ESC qualified-fetal bovine serum
(FBS) (Invitrogen), 100 U/mL penicillin and 100 µg/mL strepto-
mycin (Invitrogen), 1 mM L-glutamine (Invitrogen), 0.1 µM
β-mercaptoethanol (Sigma), and 1,000 U/mL of leukemia
inhibitory factor (LIF; Chemicon). For ESC seeding in micro-
wells, 200 µL of cell suspension (1×106 cells per mL) was spread
on a glass slide containing microwells. EBs were spontaneously
formed and size-controlled within microwells while cultured
in alpha Minimal Essential Medium (MEM; Invitrogen) contain-
ing 15% heat-inactivated FBS, and 100 U/mL penicillin and
100 µg/mL streptomycin (Invitrogen) with daily exchange
of medium.
Reverse Transcription Polymerase Chain Reaction (RT-
PCR). The RNA of collected EBs was extracted using RNeasy
kit (Qiagen) by following the manufacturer’s instructions.
RT-PCR was performed using a PTC-100TM thermal cycler
(MJ Research Inc.) by following the manufacturer’s instruc-
tions of SuperScriptTM III One-Step RT-PCR System with Plati-
num Taq kit (Invitrogen). cDNA synthesis was processed at
55 oC for 20 min with 80 ng of total RNA, followed by an
initial denaturation step at 94 oC for 2 min. PCR amplifica-
tion process was then carried under the following conditions:
15 s of denaturing at 94 oC, 30 s of specific primer annealing
temperature, and 45 s of extension at 68 oC. Information of
the primers used is listed in a supplementary table (Table I).
After amplification, PCR products were loaded on 1.2% (w/v)
agarose gels containing 0.5 µg/mL of ethidium bromide.
Fluorescence was developed under UV light using a gel doc-
umentation system (Gel Logic 100 Imaging System, Kodak).
Each gene expression was normalized by a correspondent
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Table I. Table of Various Genes Examined in this Study, Related to Early Development and Vascular/Cardiac Differentiation
Gene Gene Product Expression in Embryo Primer Sequences Size A.T.
Fgf5 Fibroblast growth factor 5 -Expressed in the pluripotent cell pool of epiblast prior to gastrulation29
F: AAAGTCAATGGCTCCCACGAA
R: CTTCAGTCTGTACTTCACTGG 464 58
Gsc 
Goosecoid, a member of 
the bicoid subfamily of the 
paired homeobox family of 
proteins
-First expressed in cells that are undergoing 
anterior migration during a short period of PS 
formation, and later during organogenesis of 
head, limbs and ventrolateral body wall30
F: CAGATGCTGCCCTACATGAAC
R: TCTGGGTACTTCGTCTCCTGG 158 60
Mixl1 MIX homeobox-like 1
-Expressed during a short period of PS formation 
prior to the transition towards mesendoderm, 
extending between posterior ExE tissues and 
PS31
F: ACGCAGTGCTTTCCAAACC
R: CCCGCAAGTGGATGTCTGG 196 60
Bra
Brachyury, a founding 
member of the T-box family 
of transcription factors
-Expressed during a short period of PS formation 
prior to the transition towards mesendoderm, 
extending between posterior ExE tissues and 
PS31,32
F: GCTTCAAGGAGCTAACTAACGAG
R: CCAGCAAGAAAGAGTACATGGC 117 60
Wnt3a
Wingless-type MMTV 
integration site family, 
member 3a (involved in 
canonical WNT pathway)
-Expressed through posterior epiblast during 
gastrulation inducing mesoderm 
development31,33
F: CTCGCTGGCTACCCAATTTG
R: CTTCACACCTTCTGCTACGCT 165 60
Dkk1 Dickkopf homologue 1
-Expressed at anterior side of the gastrulating 
embryo,3 the extracellular inhibitor of canonical 
Wnt signaling pathway34
F: CTCATCAATTCCAACGCGATCA
R: GCCCTCATAGAGAACTCCCG 105 60
Sox17 SRY (sex determining region Y)-box 17
-Expressed in definitive endoderm and its 
descendants35
F: GATGCGGGATACGCCAGTG
R: CCACCACCTCGCCTTTCAC 136 60
Foxa2 Forkhead box protein A2 -Expressed in the posterior epiblast and later confined to anterior definitive endoderm36
F: CCCTACGCCAACATGAACTCG
R: GTTCTGCCGGTAGAAAGGGA 222 60
Bmp4 Bone morphogenic protein -Extends through ExE ecto-/mesoderm affecting posterior PS31
F: TTCCTGGTAACCGAATGCTGA
R: CCTGAATCTCGGCGACTTTTT 114 60
Foxf1a Forkhead box protein F1a
-Expressed in ExE mesoderm (allantois, amnion 
and yolk sac) as well as lateral plate 
mesoderm31,37,38
F: ACGCCGTTTACTCCAGCTC
R: CGTTGTGACTGTTTTGGTGAAG 183 60
Afp Alpha-fetoprotein
-Expressed in ExE endodermal descendants such 
as visceral and yolk sac endoderm, and later in 
endodermal lineage tissues such as fetal liver39,40
F: TCCAGAACCTGCCGAGAGTT
R: CTGGGGCATACATGAAGGGG 107 60
Ihh Indian Hedgehog -Expressed in visceral yolk sac endoderm39 F: CTCTTGCCTACAAGCAGTTCAR: CCGTGTTCTCCTCGTCCTT 156 60
Flk1
Fetal Liver Kinase 1 also 
known as vascular endo-
thelial growth factor 
receptor 2 (VEGFR-2)
-Expressed in most of the mesodermal lineage 
cells such as progenies of blood, vascular cells41
F: TTTGGCAAATACAACCCTTCAGA
R: GCAGAAGATACTGTCACCACC 133 60
Vegf Vascular endothelial growth factor
-Expressed mainly in embryonic erythroid 
development42
F: CAACATCACCATGCAGATTATGC 
P: CCACAGGGACGGGATTTCTTG 186 60
Gata1 GATA family of zinc finger transcription factor 1
-Expressed prior to or during the onset of 
erythroid development43
F: TGGGGACCTCAGAACCCTTG
R: GGCTGCATTTGGGGAAGTG 134 60
Wnt5a
Wingless-type MMTV inte-
gration site family, member 
5a (involved in non-canoni-
cal WNT pathway)
-Expressed in vasculature of embryonic tissues 
acting as angiogenic signalling factor on 
endothelial cells44
F: CAACTGGCAGGACTTTCTCAA
R: CATCTCCGATGCCGGAACT 128 60
Cd31
Cluster of differentiation 
31 also known as platelet 
endothelial cell adhesion 
molecule (Pecam-1)
-Expressed in the early endothelial precursors 
during vascular development45
F: TGCACCCATCACTTACCACC
R: CTTCATCCACCGGGGCTATC 197 60
Tie2 A tyrosine-protein kinase receptor of angiopoietin
-Expressed in the regions where angiogenesis 
occurs46
F: GAGTCAGCTTGCTCCTTTATGG
R: AGACACAAGAGGTAGGGAATTGA 77 60
Vecad
Vascular endothelial cadherin 
also known as Cd144 (Clus-
ter of Differentiation 144)
-Expressed in vascular development47 F: CACTGCTTTGGGAGCCTTCR: GGGGCAGCGATTCATTTTTCT 167 60
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housekeeping gene expression (Hprt).
Immunocytochemistry. EBs were collected from microwells
by gentle PBS pipetting, and fixed for 20 min at room tem-
perature in 4% (w/v) paraformaldehyde (PFA; BDH Labora-
tory Supplies). The fixed samples were cryo-sectioned (10 µm)
to stain the center area of EBs. For staining 2D-spread EBs,
EBs collected from microwells were transferred onto lami-
nin-coated 4-well chamber slides (Vector Laboratories) and
then cultured for 7 days, followed by general immunocytochem-
istry processes. Briefly, the samples were treated with 0.2%
(v/v) Triton-X-100 (BDH Laboratory Supplies) for 45 min at
room temperature and washed twice with PBS. The samples
were then incubated with 3% (v/v) blocking goat, donkey or
rabbit serum (Vector Laboratories) in primary diluents com-
posed of 0.05% (w/v) bovine serum albumin (BSA; Sigma-
Aldrich), 0.01% (w/v) NaN3 (Sigma-Aldrich) in PBS for 30 min
at room temperature. The serum solution was removed and
the samples were incubated with primary antibodies diluted
in primary diluents at 4 oC overnight followed by two washes
and incubation with secondary antibodies diluted in second-
Table I. (continued)
Gene Gene Product Expression in Embryo Primer Sequences Size A.T.
Nkx2.5 Cardiac NK2 homeobox protein 5
-First expressed in mesodermal cells specified to 
form heart and throughout the whole heart 
tissue formation48
F: GACAAAGCCGAGACGGATGG
R: CTGTCGCTTGCACTTGTAGC 222 60
Gata4 GATA family of zinc finger transcription factor 4
-First expressed in yolk sac endoderm, and later 
in cardiac tissue, gut epithelium and gonads49
F: CCCTACCCAGCCTACATGG
R: ACATATCGAGATTGGGGTGTCT 139 60
Wnt11
Wingless-type MMTV inte-
gration site family, member 
11 (involved in non-canoni-
cal WNT pathway)
-Expressed in the developing and postnatal 
heart50
F: GCTGGCACTGTCCAAGACTC
R: CTCCCGTGTACCTCTCTCCA 250 60
Tbx5 T-box-containing transcription factor
-Expressed in the developing heart and 
specification of upper limbs51
F: ATGGCCGATACAGATGAGGG 
R: TTCGTGGAACTTCAGCCACAG 207 60
Nfatc1 Nuclear factor of activated T-cells, cytoplasmic 1
-Exclusively expressed in the initiation of 
endocardial differentiation during cardiac 
valve development52
F: GACCCGGAGTTCGACTTCG
R: TGACACTAGGGGACACATAACTG 97 60
Nrg1 Neuregulin 1, epidermal growth factor family member
-Expressed in developing endocardium during 
epithelial-to-mesenchymal transition52
F: AGTGCCCAAATGAGTTTACTGG
R: AGTTCCTCCGCTTCCATAAATTC 97 60
Oct4
Octamer-binding transcrip-
tion factor 4 also known as 
a POU-family transcrip-
tion factor
-Expressed in totipotent embryonic cells and 
downregulated through developmental 
progress53
F: GGCGTTCTCTTTGGAAAGGTGTTC
R: CTCGAACCACATCCTTCTCT 302 55
Hprt Hypoxanthine-guanine phosphoribosyltransferase
-HPRT RNA levels are known to be very low in 
a cell, which makes it suitable as an endogenous 
mRNA control in RT-PCR for highly sensitive 
quantification of low copy or rare mRNAs.
F: GTTAAGCAGTACAGCCCCAAA
R: AGGGCATATCCAACAACAAACTT 131 60
Table II. Table of Antibodies Used in this Study
Antigens Primary Antibody (company, dilution) Secondary Antibody (company, dilution)
Immuno-
cytochemistry
Laminin Rabbit polyclonal (Abcam, 1/100)
Alexa Fluor® 488 goat anti-rabbit IgG 
(Invitrogen, 1/300)
Alpha-fetoprotein (Afp) Goat polyclonal (Santa Cruz, 1/50)
Alexa Fluor® 594 donkey anti-goat IgG 
(Invitrogen, 1/300)
Cadherin-3 (cdh3) Mouse monoclonal (Santa Cruz, 1/50)
Alexa Fluor® 488 goat anti-mouse IgG 
(Invitrogen, 1/300)
Cluster of differentiation 31 
(Cd31)
Mouse monoclonal 
(Abcam, 1/100)
Alexa Fluor® 488 goat anti-mouse IgG 
(Invitrogen, 1/300)
Vascular endothelial cadherin 
(VE-cad)
Mouse monoclonal 
(Abcam, 1/100)
Alexa Fluor® 594 rabbit anti-mouse IgG 
(Invitrogen, 1/300)
Heavy chain cardiac myosin 
(MHC)
Mouse monoclonal 
(Abcam, 1/100)
Alexa Fluor® 488 goat anti-mouse IgG 
(Invitrogen, 1/300)
Flowcytometric 
analysis
Cd31 Anti-mouse Cd31-Phycoerythrin (PE) monoclonal antibody (R&D Systems, 1/200)
Control IgG IgG2B Isotype Control-PE (R&D Systems, 1/300)
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ary diluents consisting of 0.05% (w/v) BSA in PBS for 45 min
at room temperature (for the whole EB staining, they were
incubated overnight at 4 oC). For dual staining, the same steps
after the first treatment of primary antibody were repeated for
the second reaction. The stained samples were washed three
times in PBS and mounted using SlowFade® Gold antifade
reagent with DAPI (Invitrogen). An inverted laser scanning
confocal microscope (SP5 X MP, Leica) and Leica applica-
tion suite (LAS) software were used to acquire 3D serial section
images of EBs. Sectioned images (2 µm thick) were scanned
in 200 MHz and then stacked by Image J (NIH). Antibodies
used in this study are listed in Table II.
Flow Cytometric Analysis. Following microwell cultures,
the microwell arrays containing EBs were washed once with
PBS to remove traces of medium and debris in culture, and then
the EBs were retrieved from the microwells by gentle PBS
pipetting. EBs were dissociated to single cell suspensions by
treatment with 0.15 Wünsch units/mL collagenase (Sigma)
solution in DMEM (Invitrogen) for 2 h and Cell stripper TM
(Mediatech) for 15 min (37 oC, 5% CO2) on a shaker. Cells
were passed through a 40 µm cell strainer (BD Falcon). The
resulting single cells were rinsed and incubated with antibodies
in the dark at 4 oC for 40 min (Table II). Dead cells stained by
DAPI (Invitrogen) were excluded from the analysis performed
using LSRFortessa flow cytometer (BD Biosciences). Positive
expression was defined as the level of fluorescence greater
than 99% of the one measured using the corresponding iso-
type-matched control antibodies (R&D systems, Inc).
Statistical Analysis. The error bars on the relative com-
parisons of gene expressions represent the standard deviation
(SD) of the mean obtained from three independent experiments
(n=3). Each comparable value from 150 and 450 µm EBs was
statistically analyzed with a Student’s t-test at a level of sig-
nificance of p<0.05.
Results
PEG Microwell-Mediated Size Control of EBs and Spon-
taneous Differentiation. In this study, PEG hydrogel micro-
well array was fabricated to modulate EB size. As shown in
Figure 1. Formation of size-controlled EBs in microwells. Soft lithography technique was used for the fabrication of poly(ethylene gly-
col) (PEG) hydrogel microwell arrays. (A) Dimensions of poly(dimethylsiloxane) stamps for generation of each microwell array. (B)
Size-controlled EBs in culture on day 5. The non-adherent surface property of PEG hydrogel allows for docking of the ESCs within the
microwells followed by their growth into EBs confined by the size of the wells. Scale bars, 200 µm for 150 µm wells and 400 µm for 450 µm
wells. (C) Phase contrast and fluorescent images of EBs made from Oct4/GFP-tagged ESCs within 150 and 450 µm sized microwells.
Scale bars, 200 µm. (D) ESCs on D0 prior to seeding in microwells. Scale bars, 100 µm. (E) Gene expressions of Oct4 expression.
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Figure 1(A), different sized PEG microwells were generated
on glass plate using PDMS molds with multi-cylinders of
150 and 450 µm in diameters. After PEG microwell fabrica-
tion, undifferentiated ESCs suspended as single cells were docked
into PEG microwells. After 30 min of incubation, undocked
ESCs were removed by gentle washing, and EBs with differ-
ent sizes could be homogenously formed in each microwells
(Figure 1(B)). There was no ESC adhesion on the bottom sur-
face of PEG microwells due to the repellent surface of PEG for
cell adhesion. Once EBs formed within microwells, spontaneous
differentiation of ESCs within EBs was evaluated by observing
Oct4-GFP expression. The time-course gradual decrease of
Oct4-GFP intensity within EBs was observed in both 150 and
450 µm EBs within PEG microwells, which was consistent to
the gradual down-regulation of Oct4 mRNA expression in RT-
PCR analysis (Figure 1(C) and (D)).
EB Size-Mediated Mesendodermal Differentiation. Accom-
panied with spontaneous differentiation of EBs within PEG
microwells, gene expressions relevant to mesendoderm forma-
tion in the different-sized EBs were investigated (Figure 2).
These mesendodermal cells are subsequently segmented to
mesoderm, the origin of cardiovascular lineage, and endoderm,
a source of inducing signals recruiting mesoderm to the car-
diomyocyte lineage.16-23 Consistent to down-regulation of Oct4,
the expression of Fgf5 mRNA were gradually down-regu-
lated over time in both sizes of EBs, indicating spontaneous
differentiation of EBs (Figure 2(A)). During spontaneous
differentiation, the transient expressions of the mesendoderm-
related genes were observed in the 450 µm EBs. The 450 µm
EBs displayed temporal distinct increase in mRNA expressions
of a mesendoderm marker, goosecoid (Gsc),20 a mesoderm
marker, brachyury (Bra),7 and an endoderm maker, Mixl1,3
especially at day 5 of EB culture and rapid down-regulation
at day 7. On the other hand, the 150 µm EBs differed from
the 450 µm EBs in the expression patterns of mesendodermal
genes over time. Although the expression of Mixl1 showed a
Figure 2. Gene expression profiles related to early developmental processes in the 150 and 450 µm EBs. (A) Gene expressions related to
mesendodermal differentiation which is subsequently segmented to mesoderm and endoderm (n=3; *, # p<0.05). (B) Phase contrast and
fluorescent images of the different-sized EBs made using Gsc/GFP-tagged ESCs. D0 show ESCs on a 2D substrate before seeding in
microwells. 150 µm EBs and 450 µm EBs on D5 and D7 in microwell culture. Scale bars, 100 µm on D0 and 200 µm in EBs on D5 and D7.
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similar trend to that in the 450 µm EBs, the transient upregu-
lation of Gsc was not found at day 5 in the 150 µm EBs. More-
over, unlike the 450 µm EBs, the expression of Bra upregulated
at day 5 was sustained until day 7 in the 150 µm EBs (Figure
2(A)). This pattern of Gsc mRNA expression in 150 µm EBs
and 450 µm EBs was consistent to the temporal higher inten-
sity of Gsc-GFP in 450 µm EBs at day 5 of EB culture within
PEG microwells (Figure 2(B)). 
EB Size-Mediated Differential Mesodermal and Endo-
dermal Differentiation. Following the characterization of
early differentiation such as mesendoderm formation in dif-
ferent-sized EBs, various gene expressions related to meso-
Figure 3. Different tissue development in the 150 and 450 µm EBs. (A) Gene expressions of visceral endoderm lineage differentiation
that is to stimulate cardiac differentiation of neighboring cells by paracrine signalling (n=3; *p<0.05). (B) Confocal microscopy images
of the different sizes of EBs at day 7 with immunofluorescence for laminin and Afp. Scale bars, 100 µm (yop) and 200 µm (bottom). (C)
Gene expression profiles related to early gastrulation of size-controlled EBs (n=3; *p<0.05). (D) Cdh3 expressions of different sized
EBs cultured for 5 days in microwells, and transferred onto laminin-coated 2D substrates for 7 days of further culturing. Yellow arrows
indicate 2D-spread EBs. Scale bars, 200 µm.
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derm formation and endoderm formation including visceral
endoderm were investigated (Figure 3). Interestingly, the gene
expressions related to visceral endoderm formation such as
Indian hedgehog (Ihh)17 and alpha-fetoprotein (Afp)14 were up-
regulated at significantly higher levels in 450 µm EBs (Figure
3(A)). In addition, immunocytochemical staining showed that a
layer of cells showing strong Afp molecular expression was
found to be at the periphery of 450 µm EB, and the high deposi-
tion of laminin, a major component of basement membrane
which is layered between ectoderm and visceral endoderm
layers,2 was found to be co-localized with the cells of this layer
(Figure 3(B)). In contrast to 450 µm EBs, 150 µm EBs showed
relatively weak gene and molecular expressions of Ihh, Afp
and laminin. Such differential endoderm formation in 150 µm
EBs and 450 µm EBs was also characterized further by various
gene expressions related to endoderm formation. RT-PCR
analysis displayed highly up-regulated gene expression pro-
file indicating endoderm formation such as Foxa2,11 Sox17,25
and visceral endoderm formation such as Wnt3a12 in 450 µm
EBs in comparison to 150 µm EBs, but showed much lower
gene expressions indicating mesoderm formation including
lateral plate mesoderm formation such as Foxf1a and Bmp4,10-26
and Dkk1, an antagonist of Wnt3a18 (Figure 3(C)). In contrast
to 450 µm EBs, 150 µm EBs was characterized by relatively
Figure 4. Cardiovascular differentiation in the 150 and 450 µm EBs. (A) Vasculogenic gene expressions of EBs of different sizes. (B)
Immunocytochemistry images of the different sizes of EBs on day 7. Cells in both sizes of EBs were positively stained with Cd31. Scale
bars, 100 µm in 150 µm EB and 200 µm in 450 µm EB. (C) Flow cytometric analysis for Cd31+ cell population in EBs of varying sizes.
(D) Vascular (Vascular endothelial cadherin (VE-cadherin) and Cd31) differentiation proceeded on the 2D substrates. EBs of different
sizes were cultured for 5 days in microwells, and then transferred onto laminin-coated 2D substrates for an additional 7 days of culture.
Scale bars, 200 µm. (E) Gene expressions of cardiac development including myocardial (Nkx2.5, Gata4, Wnt11, and Tbx5) and endocar-
dial (Nfatc1 and Nrg1) differentiation. (F) Fluorescent and phase contrast images of the different sizes of EBs made from Nfatc1-nuc-
mCherry ESCs. Scale bars, 100 µm. (G) Cardiac (Heavy chain cardiac myosin (MHC)) lineage differentiation proceeded on the 2D sub-
strates. Scale bars, 200 µm.
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higher gene expressions of Bmp4, Foxf1a and Dkk1. The dif-
ferential gene expression profile of ESCs in 150 µm EBs were
characterized by strong molecular expression of Cdh3 known
to be expressed mostly in lateral plate mesoderm4 in the replated
culture of 150 µm EBs on a laminin-coated tissue culture plate
for 7 days (Figure 3(D)).
EB Size-Mediated Differential Cardiogenic and Endo-
thelial Differentiation. Finally, accompanied with early dif-
ferential endoderm and mesoderm formation in 150 µm EBs
and 450 µm EBs, further cardiogenic and endothelial differ-
entiation was characterized by gene expression analysis, flow
cytometric analysis, and immunocytochemical staining. As shown
in Figure 4(A), gene expressions related to vascular/endothe-
lial differentiation such as Flk1, Vegf, Gata1, Tie2, Cd31, and
Wnt5a were highly up-regulated in 150 µm EBs. Immunocy-
tochemical staining obtained from 7 day-cultured EBs showed
stronger molecular expression of Cd31 in 150 µm EBs (Fig-
ure 4(B)). Flow cytometric analysis also showed the higher
increase of Cd31+ population from 4.53% to 12.1% in 150 µm
EBs (Figure 4(C)). In addition, the vasculogenic culture of the
replated EBs showed well developed VE-cadherin and higher
Cd31 expressions in 150 µm EBs compared to those in 450 µm
EBs (Figure 4(D)). These results represented that ESCs in
150 µm EBs tended to differentiate towards endothelial lineage
compared to the cells in 450 µm EBs. On the other hand, the
expressions of cardiogenic genes such as Nkx2.5, Gata4, Wnt11,
Tbx5, Nfatc1, and Nrg1 were up-regulated at higher levels in
450 µm EBs in comparison to 150 µm EBs (Figure 4(E)), which
was consistent to immunocytochemical results showing the
relatively higher molecular expression of Nfatc1 in 450 µm EBs
(Figure 4(F)) and of MHC in the cardiogenic culture of replated
EBs (Figure 4(G)). These results represented that ESCs in
450 µm EBs tended to differentiate towards cardiogenic lin-
eage compared to cells in 150 µm EBs.
Discussion
In recent years, microscale biotechnology has opened a new
area in the studies of stem cells with the ability to regulate
cellular behaviors under controlled microenvironments, and
has provided more efficient tools to study cell biology. Micro-
fabrication-mediated control of physical environment around
cells in micro-scale could allow the precise modulation of
cell to cell interaction. In our previous studies, PEG hydrogel
microwell arrays were fabricated to culture ESCs in micro
scale, and EB sizes could be modulated in a controlled manner
via self-aggregation of ESCs within a restricted space with
repellent surface against cell adhesion.6-9 Although many stud-
ies reported time-dependent ESC differentiation via formation
of three germ layers within EBs, our previous study showed
that ESC differentiation fate could be also controlled by EB
sizes. During suspension culture of EBs, time-dependent
increase of EB size approximately from 150 to 450 µm until
day 5 was found, and this finding suggested that ESC differ-
entiation might not be influenced only by culture time or EB
size independently. Therefore, the EB size-mediated ESC
differentiation was evaluated by controlling EB size in microfab-
ricated microwell arrays at the same period of culture, and showed
that large EBs generated preferential cardiac differentiation
and small EBs generated preferential endothelial differentia-
tion, which was controlled by differential Wnt5a and Wnt11
expressions according to EB size.27 However, the precise
underlying biology to determine both lineage specific differen-
tiations in different sized EBs has not been elucidated.
Hence, in this study, a series of gene and molecular expres-
sions related to early developmental events during EB formation
to influence cardiac and endothelial lineage differentiation
were investigated. The gradual decrease of Oct4 (Figure 1(C),
(D), and (E)) and Fgf5 (Figure 2(A)) expressions represented
spontaneous differentiation of EBs formed within microwells,
which corresponded to the increase in the intensity of goose-
coid-GFP of EBs (Figure 2(B)). The upregulated mRNAs of
a mesendoderm marker, goosecoid,20 a mesoderm marker,
brachyury,7 and an endoderm maker, Mixl1,3 indicated spon-
taneous mesendoderm formation in 150 µm EBs and 450 µm
EBs under our culture condition, while mesendoderm forma-
tion was found to be higher in 450 µm EBs (Figure 2(A)). It
was reported that the goosecoid expression indicating mes-
endoderm is a divergent point for mesoderm and endoderm.20
In this study, the development of endoderm and mesoderm
during EB formation within microwells was further charac-
terized by assessing gene expression profiles. Relatively higher
endodermal differentiation including visceral endoderm for-
mation was found in 450 µm EBs, which was characterized
by highly upregulated expression of Ihh which is known to
be expressed in the visceral endoderm17 and Afp, a visceral endo-
derm marker14 (Figure 3(A)). This was consistent to the high
deposition of laminin at outer region of EB in immunocyto-
chemical analysis (Figure 3(B)). Laminin is a major component
of basement membrane which is layered between ectoderm
and visceral endoderm layers, and the basement membrane
organization is known to be essential for functioning of vis-
ceral endoderm as programmed in the early developmental
processes.2 Such a formation of highly developed endoderm
in 450 µm EBs was also proven by various gene expressions
displaying the endoderm formation such as the expressions
of Sox17,25 Foxa211 and visceral endoderm formation such as
Wnt3a.12 In contrast to ESC differentiation in 450 µm EBs,
ESC differentiation in 150 µm EBs was characterized by rel-
atively higher gene expressions of the mesoderm formation such
as Bmp4 and Foxf1a. It is well known that Foxf1a is downstream
target of Bmp4 in mesodermal signaling,26 while expressed
in lateral plate mesoderm.10 Such mesoderm formation in 150 µm
EBs was also characterized by the molecular expression indicat-
ing well developed Cdh3 (also called as P-cadherin), which
known to be expressed mostly in lateral plate mesoderm.4
Furthermore, the relatively higher mRNA expression of Dkk1,
known as an antagonist of Wnt3a,18 was also found in 150 µm
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EBs, which might be related with the lower expression of
Wnt3a, known to be expressed in visceral endoderm, in compar-
ison with 450 µm EBs. These results of gene and molecular
expressions related to the early developmental events repre-
sented that ESC differentiation in 450 µm EBs was charac-
terized by well-developed visceral endoderm formation and
ESC differentiation in 150 µm EBs was characterized by well-
developed lateral plate mesoderm. 
The preferential early differentiation of ESCs to visceral
endoderm in 450 µm EBs and to lateral plate mesoderm in
150 µm EBs supported further cardiogenic differentiation in
450 µm EBs and endothelial differentiation in 150 µm EBs
(Figure 4). Consistent to our previous study,27 150 µm EBs
showed preferential endothelial differentiation, which was proven
by relatively higher gene expressions such as Flk1, Vegf, Gata1,
Tie2, Cd31, and Wnt5a in vasculogenic culture of the replated
150 µm EBs in comparison with that of 450 µm EBs. Such
enhanced endothelial differentiation was also characterized by
VE-cadherin and Cd31 molecular expressions (Figure 4(D)).
In addition, preferential cardiogenic differentiation was devel-
oped in cardiogenic culture of the replated 450 µm EBs, which
was proven by the upregulated gene expressions such as Nkx2.5,
Gata4, Wnt11, Tbx5, Nfatc1, and Nrg1, as well as relatively
higher molecular expression of MHC. It has been well proven
that visceral endoderm plays a key role of controlling cardiac
mesoderm formation and further cardiogenesis,25 and lateral
plate mesoderm supported endothelial differentiation and
vasculogenesis.6
Conclusions
This study demonstrated that a microfabrication technique
provided an efficient culture platform to control and generate
homogenous EBs in their size. Further, different preferences
of lineage commitments towards cardiac and endothelial lin-
eages in the EBs of different sizes were attributed to the dis-
criminated development of visceral endoderm in 450 µm EBs
and lateral plate mesoderm in 150 µm EBs, respectively. Our
findings in this study could introduce an interesting insight of
EB’s developmental progress based on their sizes and a new
parameter to control ESC differentiation.
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